Chemical activators of Olr480 initiate their effects by engaging with various receptors on the cell surface or by directly influencing intracellular signaling molecules. Epinephrine and norepinephrine can activate Olr480 by binding to their respective adrenergic receptors. This receptor engagement sets off a signaling cascade that cumulates in the activation of Olr480, facilitated by the action of secondary messengers and kinases which are intrinsically associated with Olr480's functionality. Isoproterenol, a beta-adrenergic agonist, also promotes Olr480 activation but does so by increasing intracellular cyclic AMP (cAMP) levels, which in turn activates protein kinase A (PKA). PKA then phosphorylates target proteins within Olr480's signaling pathway, leading to its activation. Similarly, dopamine exerts its effect through dopamine receptors, initiating a cascade that also converges on cAMP production and subsequent PKA-mediated activation of Olr480.
Forskolin, on the other hand, bypasses receptor-mediated processes and directly stimulates adenylyl cyclase, thus raising cAMP levels and activating PKA, which then engages Olr480. Histamine and serotonin activate Olr480 via their respective receptors, which, when stimulated, lead to the activation of secondary messenger systems that ultimately activate Olr480. Prostaglandin E2 and glucagon similarly invoke Olr480 activation through their specific receptors and the resulting surge in cAMP levels. Adenosine activates Olr480 through A2 adenosine receptors, which elevate cAMP and activate PKA, subsequently leading to Olr480 activation. IBMX and caffeine, while not directly binding to Olr480, still promote its activation; IBMX through the inhibition of phosphodiesterases, causing an increase in cAMP levels, and caffeine by antagonizing adenosine receptors, leading to a similar rise in cAMP. Both result in PKA activation and phosphorylation of proteins that are part of Olr480's signaling network.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
Epinephrine activates Olr480 by binding to adrenergic receptors which are associated with the protein's function. This interaction promotes a signaling cascade that results in the activation of Olr480 through a downstream effect on secondary messengers and kinases directly related to Olr480's activity. | ||||||
L-Noradrenaline | 51-41-2 | sc-357366 sc-357366A | 1 g 5 g | $326.00 $485.00 | 3 | |
Norepinephrine activates Olr480 via its interaction with noradrenergic receptors that are functionally linked to Olr480 activation. This binding triggers a signaling pathway that leads to the activation of Olr480 through the regulation of cellular messengers and enzymes that directly stimulate Olr480 activity. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol activates Olr480 by stimulating beta-adrenergic receptors, leading to increased cAMP levels which then activate protein kinase A (PKA). PKA phosphorylates target proteins that are part of the same pathway as Olr480, resulting in the activation of Olr480. | ||||||
Histamine, free base | 51-45-6 | sc-204000 sc-204000A sc-204000B | 1 g 5 g 25 g | $94.00 $283.00 $988.00 | 7 | |
Histamine activates Olr480 by binding to histamine receptors that are connected to the signaling pathways involving Olr480. The engagement of these receptors leads to the activation of second messenger systems that directly activate Olr480. | ||||||
PGE2 | 363-24-6 | sc-201225 sc-201225C sc-201225A sc-201225B | 1 mg 5 mg 10 mg 50 mg | $57.00 $159.00 $275.00 $678.00 | 37 | |
Prostaglandin E2 activates Olr480 by interacting with prostaglandin receptors, which leads to an increase in cAMP levels. This rise in cAMP activates PKA, and subsequently, PKA activates Olr480 through phosphorylation mechanisms within the Olr480 associated signaling pathways. | ||||||
Dopamine | 51-61-6 | sc-507336 | 1 g | $290.00 | ||
Dopamine activates Olr480 through its dopamine receptors, which, upon binding, initiate a signaling cascade that results in the production of cAMP. The generated cAMP activates PKA, and PKA then activates Olr480 by phosphorylating specific substrates that lead to Olr480 activation. | ||||||
Serotonin hydrochloride | 153-98-0 | sc-201146 sc-201146A | 100 mg 1 g | $118.00 $187.00 | 15 | |
Serotonin activates Olr480 via serotonin receptors that, when bound to serotonin, initiate a series of intracellular events culminating in elevated cAMP levels. This increase in cAMP activates PKA, which then activates Olr480 as it phosphorylates proteins within the signaling pathway that Olr480 is a part of. | ||||||
Adenosine | 58-61-7 | sc-291838 sc-291838A sc-291838B sc-291838C sc-291838D sc-291838E sc-291838F | 1 g 5 g 100 g 250 g 1 kg 5 kg 10 kg | $34.00 $48.00 $300.00 $572.00 $1040.00 $2601.00 $4682.00 | 1 | |
Adenosine activates Olr480 by binding to A2 adenosine receptors which elevates intracellular cAMP levels. The increased cAMP activates PKA, and PKA in turn activates Olr480 through phosphorylation of proteins within the signaling network that includes Olr480. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX activates Olr480 by inhibiting phosphodiesterases, leading to increased levels of cAMP within the cell. The accumulation of cAMP activates PKA, and this activation translates into activation of Olr480 via phosphorylation of proteins that are part of Olr480's signaling pathway. | ||||||
Caffeine | 58-08-2 | sc-202514 sc-202514A sc-202514B sc-202514C sc-202514D | 50 g 100 g 250 g 1 kg 5 kg | $33.00 $67.00 $97.00 $192.00 $775.00 | 13 | |
Caffeine activates Olr480 by antagonizing adenosine receptors, which indirectly leads to an increase in cAMP levels. This elevation of cAMP activates PKA, and the activated PKA then activates Olr480 through the phosphorylation of proteins that are functionally linked to Olr480's activity within its specific signaling pathway. | ||||||